Authors
Latest:
Pharmacists at the FDA: Drug Information SpecialistsAgents of regulatory guidance, drug problem reports, and whistleblowers.
Latest:
Pharmacists at the FDA: Drug Information SpecialistsAgents of regulatory guidance, drug problem reports, and whistleblowers.
Latest:
New Institute Aims to Get the Medications RightComprehensive medication management may lower costs and improve lives.
Latest:
Discount Cards: A Rebuttal"The real problem to be solved is “Why do patients struggle to buy their prescriptions?” writes Frisch.
Latest:
Opinion: Clinician Burnout is Everyone's ProblemHow can we protect the health of the millions of people who protect our own?
Latest:
Physician Dispensing and the Opioid CrisisPharmacists must continue to minimize the convenience gap between physician and pharmacy.
Latest:
Physician Dispensing and the Opioid CrisisPharmacists must continue to minimize the convenience gap between physician and pharmacy.
Latest:
Birth Control Services Help Attract and Keep PatientsPrescribing more hormonal methods is an important expansion of existing services and offerings.
Latest:
New Drug Review: Vraylar for Bipolar I DisorderCariprazine demonstrated greater improvement on the MADRS.
Latest:
Opinion: Patient-Centered Care and the Heart of Independents"Community pharmacies have reasons to be optimistic..." writes Jhaveri.
Latest:
New Drug Review: Pretomanid for Highly Drug Resistant TuberculosisIndicated as part of a three-drug oral combination.
Latest:
Independent Pharmacy: A Day in the LifeSimon Murray, MD, recently spent the day with Chris Castagna, RPh, an independent pharmacist.
Latest:
Opinion: The Truth About ARCOS and the Opioid EpidemicThe DEA had access to information about where opioids were being sold, but didn’t act on it. Why?
Latest:
New Drug Review: Tafamidis Meglumine for CardiomyopathyApproved in May 2019, granted to FoldRx, a subsidiary of Pfizer.
Latest:
New Drug Review: Tafamidis Meglumine for CardiomyopathyApproved in May 2019, granted to FoldRx, a subsidiary of Pfizer.
Latest:
Toxicity Management Crucial When Combining Novel AgentsOff-label drug combinations are increasingly being used in cancer treatments, but there is the potential for overlapping or additive toxicities, explained a speaker at the 2023 HOPA Annual Conference.
Latest:
Pharmacists Can Help Patients as Signs of Normalcy ReturnAlthough COVID-19 remains a real threat, it seems we are now progressing toward a return to normalcy thanks to the widespread availability of vaccines and tireless efforts of our health care workers.
Latest:
Build a Successful Hospital Pharmacy Analytics ProgramLeverage internal partnerships and demonstrate the value of data
Latest:
Can Pharmacists be Blamed as Co-Conspirators in the Opioid Crisis?What the law says about pharmacists’ role in the opioid crisis-and how to protect yourself.
Latest:
New Measles and Rubella Vaccine Found to be Safe and EffectiveMebella is another weapon in the global fight to eradicate these diseases.
Latest:
All Ages Need Education on SunscreenData from one study showed younger women more likely to use sunscreen than older adults.
Latest:
Relying on Your Distributor Through Natural DisastersThe critical role of distributors amid natural disasters, and strategies to protect and maintain the pharma supply chain
Latest:
The Impact of Patents and Exclusivities on FDA’s Approval of Generic DrugsWhat are some of the factors affecting whether a brand-name drug has generic competition?
Latest:
Lefamulin (Xenleta) for Community Acquired Bacterial PneumoniaLefamulin was approved by the FDA in August 2019 for the treatment of CABP.
Latest:
Here’s a Tip: More Money Is the SolutionIn many industries, tipping is the norm. Pharmacists would just like to receive payment for services rendered.
Latest:
Sunosi for Excessive Sleepiness in Adults with Narcolepsy or Obstructive Sleep ApneaSolriamfetol (Sunosi, Jazz Pharmaceuticals) to treat excessive sleepiness in adult patients with narcolepsy or obstructive sleep apnea was approved on March 20, 2019.
Latest:
FDA: Simlandi Becomes Third Interchangeable Humira Biosimilar After ApprovalSimlandi is the only biosimilar to Humira on the market that is high-concentration, citrate-free, and interchangeable.
Latest:
Debunking 4 Common Myths About the FluIt’s never too far into flu season to educate patients.
Latest:
Cannabis Consulting: Are You Ready?Most pharmacists are moderately to not-at-all comfortable answering patient questions about cannabis. That needs to change.
